Stock Spotlight Archives - Page 49 of 383

MondayNov 13, 2023 2:57 pm

QualityStocksNewsBreaks – Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) (FWB: HF2) Catering to Global EV Industry Supply Chain

Reflex (CSE: RFLX) (OTCQB: RFLXF) (FWB: HF2), a strategic minerals company, has centered its corporate mission around locating and developing economic properties within the advanced materials space to cater to the rapidly growing needs of the global electric vehicle industry supply chain. “In mid-August, Reflex Advanced Materials announced that it would be issuing 100,000 new common shares of its capital, the penultimate step needed to fulfil a mineral property option payment agreement the company had entered in 2021 for its Zigzag lithium project. Located near Crescent Lake, Ontario and consisting of eight mining claims totaling approximately 2,710 hectares, the Zigzag…

FridayNov 10, 2023 3:45 pm

QualityStocksNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0) Providing a Confidential, Safe Way to Store Data

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0) is a cybersecurity and internet privacy provider of Swiss-hosted solutions for secure and private communications. “Sekur Private Data distributes a communications suite that offers encrypted and private email, the only Swiss-hosted privacy VPN, and a secure and private messaging application, catering to consumers, SMBs, enterprises, and governments. Unlike other competitors in the industry, Sekur owns 100% of its own infrastructure without relying on third-party cloud services like Amazon Web Services, Microsoft Azure Cloud or Google Cloud infrastructure,” a recent article reads. “With all the threats, including dual ransomware attacks, Sekur offers…

FridayNov 10, 2023 2:36 pm

QualityStocksNewsBreaks – Why Mountain Top Properties Inc. (MTPP) Is ‘One to Watch’

Mountain Top Properties (OTC: MTPP) specializes in property management, property technology (“PropTech”) and real estate redevelopment. “The company’s flagship subsidiary is Mountain Top Realty Inc., the managing partner of its first real estate fund focused on residential redevelopment in the prestigious and storied Hamptons, New York, beachfront communities. Mountain Top Properties is also the lead investor in blockchain-enabled industrial and warehouse flex space HQXpress, which services the warehousing, reverse logistics and liquidation markets. The company is in negotiations for the addition of AI-powered technologies that promise to simplify real estate services, including purchasing and sales,” a recent article reads. “Mountain…

ThursdayNov 09, 2023 3:30 pm

QualityStocksNewsBreaks – SOHM Inc.’s (SHMN) ABBIE Technology Poised to Make a Difference in the Lives of Millions

SOHM (OTC: SHMN), a global generic drug innovator, recently completed the acquisition of a disruptive stem cell technology ABBIE (A Binding Based Integrating Enzyme) and patents from CGA Intellectual Holdings Inc. “[The acquisition] will allow the company to create regenerative medicine and cosmeceutical products for commercialization during the next year. SOHM’s acquisition of ABBIE grants it the ability to edit genes of a large number of cell types at different stages in their life cycles, overcoming the limitations of current cell editing and cell engineering technologies, according to the company… SOHM intends to use ABBIE to edit the genes of…

WednesdayNov 08, 2023 3:45 pm

QualityStocksNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB), GEDi Cube Combine to Transform Medicine Through AI and Biotherapeutics

Renovaro BioSciences (NASDAQ: RENB), a preclinical biotechnology company involved in the development of enhanced gene, cell and immunotherapy platforms that modulate immune responses against cancers and infectious disease, and GEDi Cube International Ltd., an AI medical technology company, recently entered a definitive agreement to combine in a stock-for-stock acquisition. “The combined company will feature two main divisions: the AI division and the immunotherapy division, according to an Oct. 2 message to shareholders from Renovaro CEO Mark Dybul, M.D. With a mission to transform medicine, the two divisions will leverage the strengths of each other yet maintain flexible independent operations. Bringing…

FridayNov 03, 2023 2:52 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-Processed CBD Proven Superior in Research

Lexaria (NASDAQ: LEXX), a global innovator in drug delivery platforms, remains on track to submit an Investigational New Drug (“IND”) application for its planned U.S. Phase 1b Hypertension Clinical Trial HYPER H23-1. “Lexaria’s IND submission builds on five previous human clinical studies conducted from 2018 to 2022 and is integral to the successful filing and review of the submission. These studies were carried out in an aggregate total of 134 healthy and hypertensive persons and evidenced significant reductions in resting blood pressure over both acute and multi-week dosing regimens… The company is only aware of a handful of other published…

FridayNov 03, 2023 2:29 pm

QualityStocksNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Introducing a More America-Centric Structure for REE Supply Chain

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a strategic metals supply chain-focused enterprise, is dedicated to securing the supply of rare earth elements (“REEs”) vital to modern computer technologies in North America. “The production and refining of REEs are largely controlled by The People’s Republic of China on the global market, and international tensions have served as a reminder that China’s supply of REEs could become costly and difficult,” a recent article reads. “Ucore is working with U.S. municipal, state and federal government entities as well as Canadian municipal, provincial and federal government entities to advance the company’s facility in…

ThursdayNov 02, 2023 2:33 pm

QualityStocksNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0) Featured in Swiss Made Cybersecurity Podcast

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a cybersecurity and internet privacy provider of Swiss hosted solutions for secure and private communications, was featured in a recent Swiss Made Cybersecurity podcast. Alain Ghiai, the founder and CEO of Sekur, joined the program’s host, Paul John Spaulding, to discuss business email compromise (“BEC”) scams and how to defend against them. “BEC, or business email compromise, essentially is the act of a hacker snooping around your emails, especially business emails because in the business world you exchange a lot of valuable… and proprietary information… So it’s the act of somebody…

FridayOct 20, 2023 3:42 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Committed to R&D, Eyeing Excellent Opportunities

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator seeking to enhance the bioavailability of multiple active pharmaceutical ingredients using its patented DehydraTECH(TM) drug delivery technology platform. The company continues to devote an increasing proportion of its resources and focus toward research and development (“R&D”) as part of its overall goal to establish areas of investigation for commercial pursuits and reduce risks of the unknown for both commercial and regulatory endeavors. “In the three months ended May 31, 2023 (‘Q3 2023’), for example, the company increased its R&D expenses 118% year over year to $1.64 million from $752,095 in Q3…

FridayOct 20, 2023 2:51 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advancing Drive Toward Potential New GBM Treatment

CNS Pharmaceuticals (NASDAQ: CNSP) recently announced rapid enrollment in its potentially pivotal study involving its flagship drug candidate, Berubicin, and is moving closer to reporting the results of its drive toward a new treatment for the effectively incurable brain cancer glioblastoma (“GBM”). “The Texas-based company has clinical trial sites operating in the U.S., Italy, France, Spain, and Switzerland, to evaluate Berubicin’s performance against standard of care alkylating chemotherapy agent Lomustine for treating recurrent GBM. GBM has been generally untreatable by anthracyclines because of their inability to cross the blood-brain barrier, but Berubicin is believed to be able to cross the…

Site Search

Company Search

Category: Stock Spotlight